Renhe Pharmacy Co.,Ltd (SHE:000650)
China · Delayed Price · Currency is CNY 5.47
+0.08 (1.48%)
Jul 29, 2026, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,573 | 7,822 | 7,974 | 9,282 | 8,666 | 12,857 | |
Market Cap Growth | -5.85% | -1.91% | -14.08% | 7.11% | -32.60% | 50.56% |
Enterprise Value | 4,123 | 4,453 | 5,370 | 6,638 | 6,739 | 11,290 |
Last Close Price | 5.47 | 5.50 | 5.46 | 6.07 | 5.49 | 8.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 20.80 | 19.89 | 16.55 | 16.36 | 15.09 | 19.33 |
Forward PE | - | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
PS Ratio | 2.06 | 2.21 | 1.96 | 1.84 | 1.68 | 2.61 |
PB Ratio | 1.07 | 1.13 | 1.17 | 1.40 | 1.35 | 2.17 |
P/TBV Ratio | 1.31 | 1.39 | 1.49 | 1.85 | 1.89 | 2.96 |
P/FCF Ratio | 9.51 | 10.07 | 29.37 | 29.66 | 8.26 | 46.26 |
P/OCF Ratio | 8.83 | 9.19 | 14.31 | 18.58 | 6.82 | 16.53 |
PEG Ratio | - | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.12 | 1.26 | 1.32 | 1.32 | 1.31 | 2.29 |
EV/EBITDA Ratio | 5.84 | 6.37 | 6.82 | 6.15 | 6.80 | 11.23 |
EV/EBIT Ratio | 6.98 | 7.62 | 8.00 | 7.03 | 7.67 | 12.24 |
EV/FCF Ratio | 5.18 | 5.73 | 19.78 | 21.21 | 6.43 | 40.62 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Debt / FCF Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 |
Net Debt / Equity Ratio | -0.58 | -0.58 | -0.55 | -0.53 | -0.55 | -0.47 |
Net Debt / EBITDA Ratio | -5.82 | -5.72 | -4.73 | -3.27 | -3.55 | -2.75 |
Net Debt / FCF Ratio | -5.15 | -5.15 | -13.73 | -11.28 | -3.36 | -9.96 |
Asset Turnover | 0.47 | 0.47 | 0.55 | 0.67 | 0.71 | 0.74 |
Inventory Turnover | 5.95 | 4.41 | 5.45 | 7.05 | 6.25 | 5.76 |
Quick Ratio | 5.98 | 5.62 | 6.61 | 5.38 | 3.45 | 3.43 |
Current Ratio | 6.58 | 6.48 | 7.57 | 6.10 | 3.93 | 4.19 |
Return on Equity (ROE) | 6.65% | 7.10% | 8.42% | 9.63% | 11.52% | 13.83% |
Return on Assets (ROA) | 4.74% | 4.80% | 5.62% | 7.82% | 7.56% | 8.69% |
Return on Invested Capital (ROIC) | 14.17% | 14.28% | 15.83% | 21.93% | 21.65% | 23.88% |
Return on Capital Employed (ROCE) | 8.30% | 8.40% | 9.80% | 14.10% | 13.60% | 15.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.88% | 5.03% | 6.04% | 6.11% | 6.63% | 5.17% |
FCF Yield | 10.52% | 9.93% | 3.40% | 3.37% | 12.10% | 2.16% |
Dividend Yield | 2.78% | 2.73% | 2.75% | 3.29% | 3.64% | 1.23% |
Payout Ratio | 57.00% | 53.53% | 58.09% | 49.26% | 24.40% | 42.59% |
Buyback Yield / Dilution | -0.67% | -0.65% | 0.34% | 0.08% | -1.13% | -9.85% |
Total Shareholder Return | 2.09% | 2.08% | 3.09% | 3.37% | 2.52% | -8.62% |